Ixmyelocel-T: Completed Phase IIb enrollment

Vericel completed enrollment of about 108 patients with advanced heart failure due to ischemic DCM in the double-blind, placebo-controlled, international Phase IIb ixCELL-DCM trial evaluating 12-20 ca...